EYE PCR Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
EYE PCR General Information
Description
Developer of an intraocular endocapsular implant designed to preserve the natural three-dimensional form and internal volume of the lens capsule. The company's platform maintains the position and stability of the implanted lens, prevents capsular fibrosis and contraction, reduces the risk of posterior capsule opacification, refractive error, visual disturbances, and lens displacement, enabling ophthalmic surgeons and their patients to achieve more predictable and stable long-term visual outcomes after lens replacement procedures.
Contact Information
Website
www.eyepcr.comCorporate Office
- Westerdoksdijk 423
- 1013 BX Amsterdam
- Netherlands
Corporate Office
- Westerdoksdijk 423
- 1013 BX Amsterdam
- Netherlands
EYE PCR Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2021 | Completed | Generating Revenue |
EYE PCR Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
EYE PCR Patents
EYE PCR Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018226788-A1 | Devices for reconstruction and tensioning of a lens capsule | Active | 01-Mar-2017 | ||
| AU-2018226788-B2 | Devices for reconstruction and tensioning of a lens capsule | Active | 01-Mar-2017 | ||
| EP-3589236-A1 | Devices for reconstruction and tensioning of a lens capsule | Pending | 01-Mar-2017 | ||
| EP-3589236-A4 | Devices for reconstruction and tensioning of a lens capsule | Pending | 01-Mar-2017 | ||
| WO-2018160800-A1 | Devices for reconstruction and tensioning of a lens capsule | Inactive | 01-Mar-2017 | A61F2/1694 |
EYE PCR Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
EYE PCR Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ITK Ventures | Venture Capital | Minority |
EYE PCR FAQs
-
When was EYE PCR founded?
EYE PCR was founded in 2018.
-
Where is EYE PCR headquartered?
EYE PCR is headquartered in Amsterdam, Netherlands.
-
What is the size of EYE PCR?
EYE PCR has 9 total employees.
-
What industry is EYE PCR in?
EYE PCR’s primary industry is Therapeutic Devices.
-
Is EYE PCR a private or public company?
EYE PCR is a Private company.
-
What is EYE PCR’s current revenue?
The current revenue for EYE PCR is .
-
Who are EYE PCR’s investors?
ITK Ventures has invested in EYE PCR.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
